PolyPid, MIS Implants partner for drug delivering dental bone-filler

Israeli drug delivery company PolyPid has partnered with U.S.-based devicemaker MIS Implants Technologies to develop a dual polymer-lipid bone-healing technology specifically for dental use. PolyPid's line of BonyPid nanodelivery platforms, recently tested in clinical trials, allows for the sustained release of drugs when pumped into damaged bones--the dental adaptation would help treat conditions such as periodontitis, an inflammatory tooth disease, with a controlled therapeutic release. Combined with MIS's specially designed implants, the companies expect to launch the technology by early 2015. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion…